Apyx Medical APYX

Jump To Section

    $

    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    .
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    -$0.03 (-2.54%)Past DayToday's Volume:
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    ,
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0

    Relative Strength Index (RSI)

    - The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.

    - The RSI is calculated using the following formula:

    RSI = 100 - (100 / (1 + RS))

    Where RS is the ratio of the average gains to the average losses over a specified period.

    - The default time period used is 14 days.

    - RSI values range between 0 and 100.

    RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)

    RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)

    RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.

    About

    Business overview of Apyx Medical (APYX)
    Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.

    Key Insights

    Critical company metrics and information

    • Latest Closing Price

      $1.19

    • Market Cap

      $44.80 Million

    • Price-Earnings Ratio

      -8.50

    • Total Outstanding Shares

      37.64 Million Shares

    • Total Employees

      252

    • Dividend

      No dividend

    • IPO Date

      April 6, 1994

    • SIC Description

      Surgical & Medical Instruments & Apparatus

    • Primary Exchange

      NASDAQ

    • Type

      Common Stock

    • Headquarters

      5115 ulmerton road, Clearwater, FL, 33760

    • Homepage

      https://apyxmedical.com

    Historical Stock Splits

    Execution DateSplit Amount
    No Historical Stock Splits

    Cash Flow Statement

    July 1, 2024 to September 30, 2024
    MetricValue
    Net Cash Flow From Operating Activities, Continuing$-4.44 Million
    Net Cash Flow, Continuing$-4.60 Million
    Net Cash Flow From Financing Activities, Continuing$-5,000
    Net Cash Flow From Operating Activities$-4.44 Million
    Net Cash Flow From Financing Activities$-5,000
    Net Cash Flow From Investing Activities$-153,000

    Income Statement

    July 1, 2024 to September 30, 2024
    MetricValue
    Preferred Stock Dividends And Other Adjustments$0
    Net Income/Loss Attributable To Noncontrolling Interest$-21,000
    Nonoperating Income/Loss$-1.03 Million
    Costs And Expenses$16.15 Million
    Income Tax Expense/Benefit$60,000
    Gross Profit$6.95 Million

    Comprehensive Income

    July 1, 2024 to September 30, 2024
    MetricValue
    Comprehensive Income/Loss Attributable To Parent$-4.72 Million
    Other Comprehensive Income/Loss$0
    Comprehensive Income/Loss$-4.72 Million
    Comprehensive Income/Loss Attributable To Noncontrolling Interest$0

    Balance Sheet

    July 1, 2024 to September 30, 2024
    MetricValue
    Noncurrent Liabilities$39.97 Million
    Liabilities$49.52 Million
    Assets$60.72 Million
    Current Liabilities$9.55 Million
    Liabilities And Equity$60.72 Million
    Equity$11.20 Million

    Historical Dividends

    Announcement DatePayment DateRecord DateAmountFrequency
    No historical dividends

    Recent Headlines From The Web

    Latest news, press releases, and media coverage about APYX from trusted financial sources
      Boost your savings and earn 4.15% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
      All TickersEarnings CalendarNews ArticlesAbout UsPrivacy & Cookies Info

      ⓒ 2025 Financhle. All Rights Reserved.